Richmond Brothers, Inc. Rockwell Medical, Inc. Transaction History

Richmond Brothers, Inc.

$152 Million
Q2 2025

A detailed history of Richmond Brothers, Inc. transactions in Rockwell Medical, Inc. stock. As of the latest transaction made, Richmond Brothers, Inc. holds 32,554 shares of RMTI stock, worth $31,577. This represents 0.02% of its overall portfolio holdings.

Number of Shares

32,554

Previous 32,554 -0.0%

Holding current value

$31,577

Previous $36,000 25.0%

% of portfolio

0.02%

Previous 0.02%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 02, 2025	SELL	$1.13 - $2.33 $144 - $298	-128 Reduced 0.39%	32,554 $36,000
Q4 2024 Feb 10, 2025	SELL	$2.01 - $4.65 $436,551 - $1.01 Million	-217,190 Reduced 86.92%	32,682 $66,000
Q3 2024 Nov 12, 2024	SELL	$1.67 - $4.4 $45,016 - $118,606	-26,956 Reduced 9.74%	249,872 $991,000
Q2 2024 Aug 12, 2024	SELL	$1.45 - $1.92 $65,863 - $87,212	-45,423 Reduced 14.1%	276,828 $487,000
Q1 2024 May 09, 2024	SELL	$1.23 - $1.86 $110,923 - $167,738	-90,182 Reduced 21.87%	322,251 $534,000
Q4 2023 Feb 08, 2024	BUY	$1.58 - $2.44 $3,287 - $5,077	2,081 Added 0.51%	412,433 $779,000
Q3 2023 Nov 02, 2023	SELL	$1.83 - $6.19 $22,457 - $75,963	-12,272 Reduced 2.9%	410,352 $853,000
Q2 2023 Aug 11, 2023	SELL	$1.8 - $5.46 $59,965 - $181,894	-33,314 Reduced 7.31%	422,624 $2.31 Million
Q1 2023 May 10, 2023	SELL	$1.03 - $2.62 $114,778 - $291,959	-111,435 Reduced 19.64%	455,938 $825,000
Q4 2022 Feb 07, 2023	SELL	$0.84 - $1.39 $48,150 - $79,677	-57,322 Reduced 9.18%	567,373 $573,000
Q3 2022 Nov 01, 2022	SELL	$1.2 - $2.11 $17,148 - $30,151	-14,290 Reduced 2.24%	624,695 $724,000
Q2 2022 Aug 12, 2022	BUY	$1.28 - $4.84 $817,900 - $3.09 Million	638,985 New	638,985 $717,000

Others Institutions Holding RMTI

# of Institutions

Shares Held

5.93M

Call Options Held

129K

Put Options Held

10.4K

View Full List

About ROCKWELL MEDICAL, INC.

Ticker RMTI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 10,675,200
Market Cap $10.4M
Description
Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iro...

More about RMTI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Richmond Brothers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Richmond Brothers, Inc. with notifications on news.

Account

Richmond Brothers, Inc. Rockwell Medical, Inc. Transaction History